Figure 6. RMSD, Protein RMSF, protein interaction and protein-ligand contacts of top docked ADMET favorable FDA-approved compounds (A-B) RMSD (C-D) Protein RMSF, (E-F) protein interaction and (G-H) protein-ligand contacts plots of Empagliflozin and Citicoline over simulations run for 100ns complexed with NLRP3.
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
